CHELSEY BROOKS: Open Payments
NPI 1538532940 · LIVERPOOL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,519 in 151 payments from 18 companies in 2025. Trend: 2023 $1,645 · 2024 $1,196 · 2025 $2,519
Food & beverage: $2,426Education: $93
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 49 | $499 |
| ABBVIE INC. | 30 | $460 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $287 |
| Janssen Biotech, Inc. | 11 | $275 |
| QOL Medical, LLC | 11 | $202 |
| Phathom Pharmaceuticals, Inc. | 7 | $110 |
| Ardelyx, Inc. | 4 | $110 |
| Gilead Sciences, Inc. | 5 | $104 |
| Lilly USA, LLC | 5 | $93 |
| PFIZER INC. | 4 | $81 |
Products named: XIFAXAN, TREMFYA, ENTYVIO, Sucraid, RINVOQ, CREON, VOQUEZNA, IBSRELA.
Industry payments across NY — which companies pay providers there.
